Development of a Method of Evaluation of Fatigue and Its Economic Impacts

  • Osami Kajimoto


If a method for the qualitative and quantitative evaluation of fatigue can be developed, it will be useful not only as a means of self-monitoring by individuals and improving occupational health, but also for facilitating the development and commercialization of antifatigue medications and food supplements. Although it is difficult to determine with precision the economic loss caused by fatigue, there is no question that the successful suppression of chronic fatigue (which is one factor responsible for the onset or exacerbation of lifestyle-related chronic diseases) will greatly contribute to decreasing medical expenditure. It is known that major signs of fatigue, which appear in the form of compromised physical and mental function, are closely related to the function of the frontal lobes (which may be the center for fatigue recognition) and of the autonomic nervous system. For this reason, the quantification of fatigue requires the development of biomarkers capable of objectively and sensitively evaluating changes in frontal lobe function (working memory, etc.) and autonomic nervous system function (pulse waves, etc.). Qualitative and quantitative evaluations of fatigue will be possible by meta-analyses of changes in biochemical, immunological, and physiological markers in blood, saliva, and urine, as well as changes in brain function imaging in the presence of mental or physical stress.


Autonomic Nervous System Chronic Fatigue Syndrome Food Supplement Mental Fatigue Chronic Fatigue Syndrome Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kitani T (2001) Fatigue science. Kodansha, Tokyo, 2–4Google Scholar
  2. 2.
    Hayaishi O (1991) Stress society and mental health. Sekai Hoken Tsushinsha, TokyoGoogle Scholar
  3. 3.
    Helmut S, Inoue M (2000) Antioxidants in disease mechanisms and therapy. Iyaku (Medicine and Drug) Journal, TokyoGoogle Scholar
  4. 4.
    Onoue H, Tajima Y, Yamamoto S, Watanabe Y (2001) Fatigue science. Kodansha, Tokyo, pp 5–17Google Scholar
  5. 5.
    Mizokawa S, Tanaka M, Matumura A, Nozaki S, Watanabe Y (2003) Recovery from fatigue: changes in local brain 2-[18F] fluoro-2-deoxy-D-glucose utilization measured by autoradiography and in brain monoamine levels of rat. Neuroscience Letters 353:169–172PubMedCrossRefGoogle Scholar
  6. 6.
    Goldman-Rakic PS (1992) Working memory and the mind. Scientific Am 22:73–9Google Scholar
  7. 7.
    Pagani M, Lucini D (1999) Chronic fatigue syndrome: a hypothesis focusing on autonomic nervous system. Clin Sci 96(1):117–25PubMedCrossRefGoogle Scholar
  8. 8.
    De Becker P, Dendale P, De Meirleir K, Campine I, Vandenborne K, Hagers Y (1998) Autonomic testing in patients with chronic fatigue syndrome. Am J Med 105(3A) 22S–26SPubMedCrossRefGoogle Scholar
  9. 9.
    Appenzeller O (1987) The autonomic nervous system and fatigue. Funct Neurol 2(4):473–85PubMedGoogle Scholar
  10. 10.
    Li Z, Jiao K, Chen M, Wang C (2002) Spectral analysis of heart rate variability as quantitative indicator of driver mental fatigue. SAE Tech Pap Ser: 6Google Scholar
  11. 11.
    Naschitz JE, Sabo E, Naschitz S, Rosner I, Rozenbaum M, Priselac RM, Gaitini L, Zukerman E, Yeshurun D (2002) Fractal analysis and reccuence quantification analysis of heart rate and pulse transit time for diagnosing chronic fatigue syndrome. Clin Auton Res 12:264–272PubMedCrossRefGoogle Scholar
  12. 12.
    Yamaguchi K (2003) Evaluation of green odor as prevention from fatigue. Program No. 107.9. 2003 Abstract Viewer/Itinerary Planner. Washington, DC, Society for NeuroscienceGoogle Scholar
  13. 13.
    Kuratsune H, Yamaguti K, Lindh G, Evengard B, Takahashi M, Machii T, Matsumura K, Takaishi J, Kawata S, Långström B, Kanakura Y, Kitani T, Watanabe Y (1998) Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseases. Int J Mol Med 2(1):51–56PubMedGoogle Scholar
  14. 14.
    Kuratsune H, Yamaguti K, Lindh G, Evengard B, Hagberg G, Matsumura K, Iwase M, Onoe H, Takahashi M, Machii T, Kanakura Y, Kitani T, Langstrom B, Watanabe Y (2002) Brain regions involved in fatigue sensation: reduced acetylcarnitine uptake into the brain. Ann Neuroimage 17(3):1256–1265CrossRefGoogle Scholar
  15. 15.
    Kuratsune H, Yamaguti K, Sawada M, Kodate S, Machii T, Kanakura Y, Kitani T (1998) Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. Int J Mol Med 1(1):143–146PubMedGoogle Scholar
  16. 16.
    Scott LV, Svec, F, Dinan T (2000) A preliminary study of dehydroepiandrosterone response to low-dose ACTH in chronic fatigue syndrome and in healthy subjects. Psychiatry Res 97(1):21–28PubMedCrossRefGoogle Scholar
  17. 17.
    Tsukada H, Lindner KJ, Hartvig P, Långström B (1994) Effect of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on the extracellular levels of dopamine and serotonin in the rat striatum: a microdialysis study with tyrosine or tryptophan infusion. Brain Res 635(1–2):59–67PubMedCrossRefGoogle Scholar
  18. 18.
    Mizuma H, Mizutani M, Nozaki S, Iizuka H, Tohyama H, Nishimura N, Watanabe Y, Kohashi R (2003) Improvement of repeated administration of 6R-tetrahydrobiopterin of 5,7-dihydroxytryptamine-induced abnormal behaviors in immature rats. Biochem Res Commun 302(1):156–161CrossRefGoogle Scholar
  19. 19.
    Inoue M, Kuratsune H, Watanabe Y (2001) Fatigue science. Kodansha, Tokyo, pp 222–228Google Scholar
  20. 20.
    Nishino Co., Ltd. (2003) HOTLINE. July editionGoogle Scholar
  21. 21.
    Ministry of Health, Labour and Welfare (2003) White Paper on the Labour Economy 2003. “Gyosei”: 498Google Scholar
  22. 22.
    National Institute of Industrial Health (2000) National occupational health research priorities, agenda and strategy of Japan. The press release of Ministry of Health, Labour and WelfareGoogle Scholar
  23. 23.
    Ministry of Health, Labour and Welfare (2003) Reports on Labour and Health 2003. Statistics and Information DepartmentGoogle Scholar
  24. 24.
    Nagano Economic Research Institute (2003) Economic monthly report. March editionGoogle Scholar
  25. 25.
    Visser JT, De Kloet ER, Nagelkerken L (2000) Altered glucocorticoid regulation of the immune response in the chronic fatigue syndrome. Ann NY Acad Sci 917:868–875PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Osami Kajimoto
    • 1
  1. 1.Department of Biomarker and Molecular BiophysicsOsaka City University Graduate School of MedicineOsakaJapan

Personalised recommendations